Navigation Links
Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
Date:5/16/2008

24-hour diastolic ambulatory blood pressure and mean seated office systolic and diastolic blood pressure as well as a number of other endpoints.

Investor event at ASH

Pharmacopeia will host a meeting for investors today, Friday, May 16th at 7:00am CDT (8:00am EDT) to review the Phase 2a study results from its PS433540 program, including a presentation by Joel Neutel, M.D., the study's lead investigator. A live webcast and 90-day archive of the presentation can be accessed on the Investors section of the company's website at http://www.pharmacopeia.com.

About PS433540

PS433540 is the first and only blood pressure product candidate in a new class of antihypertensives known as Dual Acting Receptor Antagonists (DARAs). PS433540 is being developed as a potential treatment for hypertension and diabetic nephropathy. PS433540 possesses two clinically validated mechanisms of action in a single molecule. There is preclinical and initial clinical data suggesting that compared to either mechanism alone, simultaneously blocking angiotensin II and endothelin 1 at their respective receptors, AT1 and ETA, may provide an improved treatment option for several cardiovascular diseases. Because PS433540 is highly selective for the AT1 and ETA receptors it is able to block the blood pressure-raising actions of angiotensin and endothelin when they bind to these receptors.

About Pharmacopeia

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including eight clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The compa
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
3. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
4. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
5. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
6. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
7. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
8. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
9. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
10. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
11. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... 11, 2014 Research and Markets ... the "Drug Injection Devices to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769 As new drugs ... list of health conditions, drug developers have increasingly ... administration process and increase the efficiency and reliability ...
(Date:12/13/2014)... , Dec. 12, 2014 HudsonAlpha ... the HiSeq X Ten sequencing system manufactured by ... HudsonAlpha to produce and analyze genomic data faster ... from the Institute,s commitment to research programs for ... HiSeq X Ten provides unprecedented capacity, speed and ...
(Date:12/13/2014)... and INDIANAPOLIS , Dec. 12, 2014 ... Chip Ganassi Racing Teams (CGRT), today announced a multi-year extension ... primary sponsor of the No. 83 Novo Nordisk Chip Ganassi ... Verizon IndyCar Series. Kimball, 29, from ... licensed driver with diabetes in the history of INDYCAR to ...
Breaking Medicine Technology:Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 2Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 4Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 5Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 6Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 7
... 25, 2011 An interesting statistic: more than half (55%) ... having a hair transplant if celebrities or public figures were ... likely to be influenced than women (57% vs. 45%). ... have openly admitted to hair restoration, including Kevin Costner, Mel ...
... Wash., Jan. 24, 2011 Cardiac Science Corporation ... AED ) and diagnostic cardiac monitoring devices, ... Army,s Research, Development, and Engineering Command for the ... indicates the Powerheart AED G3 Pro complies with U.S. ...
Cached Medicine Technology:More and More Celebrities Are Embracing Hair Restoration 2Cardiac Science Awarded US Military Certification 2Cardiac Science Awarded US Military Certification 3Cardiac Science Awarded US Military Certification 4
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... holiday party season fast approaching, a new study reveals that ... arrests have fewer drunk drivers on their roads. The ... vigilantly are better able to deter inebriated revelers from getting ... new laws are being passed regarding drinking and driving," said ...
(Date:12/15/2014)... December 15, 2014 Veretekk.com, Inc. announced ... Ocean Avenue. JM Ocean Avenue has secured exclusive ... online automated marketing system. JM Ocean Avenue is ... merger of Ocean Avenue and JM International, with partial ... Billion per year company. , “After nearly 2 decades ...
(Date:12/15/2014)... Health Dialog, a leading provider of ... has received Patient Oriented Accreditation from the National ... Management (DM) Programs for asthma, congestive heart failure, ... and diabetes. This marks the 12th continuous year ... Management (DM) Programs, reaffirming Health Dialog’s focus and ...
(Date:12/15/2014)... December 15, 2014 Emergo Group, Inc., ... 26 countries in North and South America, Europe, the ... from industry participants for its 2015 Medical Device Industry ... to identify upcoming business and market trends as well ... The survey targets areas including:, , ...
(Date:12/15/2014)... 15, 2014 For the second year in ... “Top 30 Coffees of 2014.” Bird Rock Coffee Roasters’ Sumatra ... Zone Ethiopia at number 10. This is the first year ... Review’s selection is ranked on quality, value, and other aspects, ... 96 out of 100, and at $17.99 for 12-ounces, was ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
... New Data Shows a Comprehensive Technology Infrastructure Improves ... Calif., March 10 Two Kaiser Permanente studies ... that a comprehensive electronic health record can increase ... maintaining clinical quality and that connecting patients directly ...
... Medical Solutions recently completed the first 1,000 ... Scorpion Offshore Inc.,s ultra-premium jackup rig, Offshore ... Offshore the first drilling contractor to provide ... advanced healthcare, direct physician attention and improved ...
... new Autism specialistsCALDWELL, N.J., March 10 Caldwell College ... Innovations in Autism Treatment and Applied Behavior Analysis ... from 8:45 a.m. to 5:15 p.m. Widely recognized leaders in the ... science based approach to learning , will speak at the ...
... 10 /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd,("Obio"/ "the Company") ... drug,TG21, against main strains of influenza virus (including avian ... process leading to clinical,trials for TG21 has already commenced. ... continue to engage prestigious institutions in USA and,China to ...
... are the two leading causes of chronic kidney disease, and during ... ensure that individuals have the information they need to take charge ... ... 10-- Diabetes and high blood pressure are the two leading causes ...
... has today announced that Guy,s and St Thomas, ... of the BigHand digital dictation workflow system, further ... patient care across a number of specialties. The ... award winning BigHand system within Oncology and Renal ...
Cached Medicine News:Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 2Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 3Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 4Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 2Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 3Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 2Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 3Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 2Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 3Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 3Health News:Guy's and St Thomas' NHS Foundation Trust extends patient care benefits of BigHand Digital Dictation 2
... Throughput Sorter RSD ProVolume ... in the field of pre-sorting and ... of considerable speed but is also ... can be integrated. Secure and tight ...
... System RCS 800 closes various plastic primary and ... way. Different tube heights and diameters can be ... be used for send-outs. The integration into other ... System RSD 800 and High Throughput Sorter RSD ...
... DS 800 selectively removes closures from various sample ... towards the rack opening in one run. The ... PVT Systems like Sorting System RS 800 (optional), ... ProVolume and Aliquoting System RSD 800A. All common ...
... offers reagents to detect sequences of ... virus 1, 2 and 3; influenza ... syncytial virus A and B. ... create homebrew tests., *Analyte ...
Medicine Products: